S243249 Monotherapy in Patients With Relapsed or Refractory Acute Leukemia With a KMT2A or NUP98 Translocation or Relapsed or Refractory AML With NPM1c Mutation
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Relapsed or Refractory Acute Myeloid Leukemia
Related studies linked through entity extraction aliases.
A Single-arm, Prospective Study of TBI + BUMEL As a Conditioning Regimen for Salvage HSCT in Patients with R/R AML
- Status
- RECRUITING
- Phase
- NA
A Safety, Tolerability and Efficacy Study of NC525 in Subjects With Advanced Myeloid Neoplasms
- Status
- TERMINATED
- Phase
- PHASE1
Selinexor in Combination With HAD or CAG Rregimens in Relapsed or Refractory Acute Myeloid Leukemia
- Status
- RECRUITING
- Phase
- PHASE3
Clinical Study of Mitoxantrone Hydrochloride Liposome Injection in Subjects With Acute Myeloid Leukemia
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study to Evaluate MK-0482 for Relapsed/Refractory Acute Myeloid Leukemia (AML) or Chronic Myelomonocytic Leukemia (CMML) (MK-0482-002)
- Status
- TERMINATED
- Phase
- PHASE1
Evaluation of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of PHI 101 for the Treatment of AML
- Status
- UNKNOWN
- Phase
- PHASE1
Pegcrisantaspase in Combination With Venetoclax for Treatment of Relapsed or Refractory Acute Myeloid Leukemia (R/R AML)
- Status
- COMPLETED
- Phase
- PHASE1
Study of AMG 330 in Combination With Pembrolizumab in Adult With Relapsed or Refractory Acute Myeloid Leukemia
- Status
- TERMINATED
- Phase
- PHASE1
A China Bridging Study of Ivosidenib in r/r AML Subjects With an IDH1 Mutation
- Status
- COMPLETED
- Phase
- PHASE1
Dexamethasone in Refractory or First Relapsed Acute Myeloid Leukemia
- Status
- TERMINATED
- Phase
- PHASE3
Study of a New Intravenous Drug, Called S65487, in Patients With Acute Myeloid Leukemia, Non Hodgkin Lymphoma, Multiple Myeloma or Chronic Lymphocytic Leukemia
- Status
- TERMINATED
- Phase
- PHASE1
AMG 176 First in Human Trial in Participants With Relapsed or Refractory Multiple Myeloma and Participants With Relapsed or Refractory Acute Myeloid Leukemia
- Status
- TERMINATED
- Phase
- PHASE1
CD123 Redirected Autologous T Cells for AML
- Status
- TERMINATED
- Phase
- EARLY_PHASE1
Dose Escalation Study in Acute Myeloid or B-Cell Acute Lymphoblastic Leukemia
- Status
- WITHDRAWN
- Phase
- PHASE1